US EditionPublished • loading... • Updated
Biotech Co. Gradalis Names Former Novartis Exec as Its New CEO
Summary by Dallas Innovates
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biotech Co. Gradalis Names Former Novartis Exec as Its New CEO
Dallas Innovates, Every Day: Here's what's new + next in North Texas. Carrollton-based Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, has named Steven D. Weinstein as its new chief executive officer. With more than two decades of experience in life sciences leadership, venture capital, and company building, Weinstein brings a track record of guiding innovative healthcare organizations from e…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
